| Acidaminococcus intestini| Acidaminococcus intestini Jumas-Bilak et al. 2007| Acidaminococcus sp. ADV 255.99| Acidaminococcus sp. D21| AIP 283.01| CCUG 50930| CIP 108586| DSM 21505| strain ADV 255.99
Normal Microbiota: Many bacteria in the gut, including Firmicutes, are part of the normal human microbiota. The microbiota is a complex community of microorganisms that plays essential roles in digestion, nutrient metabolism, and immune system modulation.
Anaerobic Nature: Being anaerobic, Acidaminococcus intestini likely thrives in the low-oxygen environment of the gastrointestinal tract. Anaerobic bacteria contribute to the fermentation of various substrates in the gut, producing metabolites like short-chain fatty acids.
Metabolic Activities: Like other members of the gut microbiota, Acidaminococcus intestini may be involved in metabolic activities, including the fermentation of specific compounds. The byproducts of bacterial fermentation can influence the local environment in the gut.
Potential Health Impacts: The specific health impacts of Acidaminococcus intestini, including any potential associations with health or disease, are not well-established. Research on individual bacterial species within the microbiota is ongoing, and understanding their roles and implications requires further investigation.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 1.28 | 6 | 15200 | 0 | 8864 | 1289 | 50 | 3864.6 | 0 | 90 | 0 %ile | 100 %ile | ||
biomesight | 22.63 | 0 | 10 | 10 | 250 | 0 | 3603 | 508.9 | 20 | 1578.5 | 20 | 200 | 0 %ile | 92 %ile |
thorne | 93.1 | 1 | 20233 | 0 | 8899 | 1060.4 | 11 | 3999.3 | 1 | 49 | 0 %ile | 100 %ile | ||
thryve | 28.61 | 0 | 18 | 1 | 54275 | 0 | 33266 | 4100.9 | 38 | 14880.3 | 4 | 1582 | 0 %ile | 98.1 %ile |
ubiome | 9.63 | 0 | 0 | 17 | 72383 | 0 | 43828 | 9189.1 | 1029 | 17672.8 | 0 | 15762 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 7.53 | 23.98 | 0.0008 | 0.0024 |
XenoGene | 1000 | 10000 | 0.1 | 1 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 25.428 % | 0.051 % | 0.173 % | 728.0 | 2863 |
BiomeSightRdp | 12.5 % | 0.381 % | 0.759 % | 4.0 | 32 |
bugspeak | 100 % | 0.007 % | % | 1.0 | 1 |
CerbaLab | 100 % | 0.014 % | 0.008 % | 3.0 | 3 |
custom | 22.034 % | 0.115 % | 0.401 % | 13.0 | 59 |
es-xenogene | 62.069 % | 0.04 % | 0.114 % | 18.0 | 29 |
Medivere | 42.857 % | 0.001 % | 0.001 % | 3.0 | 7 |
Thorne | 77.273 % | 0.142 % | 0.418 % | 68.0 | 88 |
Thryve | 26.464 % | 0.438 % | 1.6 % | 366.0 | 1383 |
uBiome | 9.596 % | 0.919 % | 1.767 % | 76.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.